Ortho Market Pressures Moderated in 3Q, Year-End Surge Unlikely
We estimate the orthopedic market grew in the low single-digits as procedure volumes recovered across most categories. Nov 21, 2022
Anika Remains On Track For 2022 Guidance
The company grew below 1% in 3Q22 due to a difficult prior year comparison, supply chain headwinds and slowly recovering elective procedures. Nov 17, 2022
SI-BONE Set for Reimbursement Tailwinds
The company grew more than 18% in 3Q22 and will benefit from substantial CMS fee increases in ASCs for 2023. Nov 15, 2022
NuVasive Focused on Long Term Growth Strategy
The company grew in high single-digits for 3Q22 on the strength of case volume recovery and its portfolio of procedural solutions. Nov 14, 2022
Treace Benefits from Commercial Investments
The company grew by more than 52% in 3Q22, spurred by accelerating contributions from its direct sale force. Nov 14, 2022
Paragon 28 Growth Driven by New Product Cadence
The company grew over 28% in 3Q22, as new product introductions attract new surgeons and drive sales force expansions. Nov 14, 2022
Orthopedic Enabling Technology Startups Focused on Value
Orthopedic enabling technology startups are finding innovative ways to empower surgeons and improve healthcare economics. Nov 11, 2022
Vericel Reduces MACI Guide on Patient Flow Downturn
The company's MACI product grew nearly 30% in the third quarter of 2022, but patient flow disruptions brought a guidance reduction. Nov 11, 2022
Globus Stabilizes At High Single Digit Growth
The company grew just over 10% in third quarter of 2022, driven by competitive rep conversions and robotic pull-through. Nov 11, 2022
ATEC’s Sector-Leading Growth Validates Approach
The company grew over 40% in 3Q22, driven by its accelerating lateral surgery business and enabling technologies like EOS. Nov 09, 2022
